Deep Track Capital »

Pacific Biosciences of California shares owned by Deep Track Capital

Quarter-by-quarter ownership of Pacific Biosciences of California (PACB) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Pacific Biosciences of California

Tip: Access up to 7 years of quarterly data

All positions including Pacific Biosciences of California held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacific Biosciences of California by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $50M 6.0M 8.35
2023-06-30 $19M 1.5M 13.30
2023-03-31 $41M 3.5M 11.58

More positions owned by Deep Track Capital

Insmed Com Par $.01 (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Intra Cellular Therapies (ITCI)
Ionis Pharmaceuticals (IONS)
Guardant Health (GH)
Immunovant (IMVT)
Alkermes SHS (ALKS)
Dynavax Technologies Corp Com New (DVAX)
Structure Therapeutics Sponsored Ads (GPCR)
Pliant Therapeutics (PLRX)
Springworks Therapeutics (SWTX)
Axsome Therapeutics (AXSM)
Bicycle Therapeutics Sponsored Ads (BCYC)
Travere Therapeutics (TVTX)
Intellia Therapeutics (NTLA)

View all positions for Deep Track Capital

Top funds holding Pacific Biosciences of California

ARK Investment Management
Vanguard Group
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Bank of New York Mellon
Jackson Square Partners
Bellevue Group
Point72 Asset Management
T. Rowe Price Associates
Dimensional Fund Advisors
Decheng Capital
VK Services
Lord, Abbett & Co
Charles Schwab Investment Management
Iron Triangle Partners

View all funds holding Pacific Biosciences of California